Revaccination with mRNA-1345 against RSV at 12 months was noninferior to primary vaccination among adults aged 50 years and older.

The best air purifiers under ₹15,000 now offer powerful filtration, smart features, and efficient performance for Indian ...

JPMorgan initiated coverage of Enanta (ENTA) with an Overweight rating and $17 price target The firm cites the recent Phase 2b data for ...

The CDC recommends “staying up-to-date with recommended immunizations” to lower the risk of hospitalization and death from ...

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the ...

The 2025–26 respiratory syncytial virus (RSV) season is shaping up to be a pivotal moment in the fight against this significant global health threat. In just the past 2 years, three products have been ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid ...

Sponsored by Pfizer Fall is here and many of us are looking forward to crisp weather, holiday traditions and getting together ...

By Melissa Patrick Kentucky Health News As temperatures drop and people spend more time indoors, the flu and other ...

Respiratory syncytial virus (RSV) is a common respiratory virus which disproportionally affects new-borns and infants.

Respiratory syncytial virus can cause severe illness especially in young infants. A new study published in Eurosurveillance shows that immunisation of children after birth reduced the risk of ...